NCM Capital Management’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $236K | Hold |
1,865
| – | – | 0.1% | 162 |
|
|
2025
Q1 | $239K | Hold |
1,865
| – | – | 0.11% | 156 |
|
|
2024
Q4 | $247K | Hold |
1,865
| – | – | 0.11% | 154 |
|
|
2024
Q3 | $272K | Hold |
1,865
| – | – | 0.13% | 141 |
|
|
2024
Q2 | $256K | Hold |
1,865
| – | – | 0.13% | 138 |
|
|
2024
Q1 | $256K | Hold |
1,865
| – | – | 0.14% | 136 |
|
|
2023
Q4 | $253K | Sell |
1,865
-170
| -8% | -$23.1K | 0.15% | 135 |
|
|
2023
Q3 | $249K | Hold |
2,035
| – | – | 0.18% | 127 |
|
|
2023
Q2 | $258K | Buy |
2,035
+20
| +1% | +$2.54K | 0.18% | 127 |
|
|
2023
Q1 | $260K | Hold |
2,015
| – | – | 0.19% | 124 |
|
|
2022
Q4 | $265K | Hold |
2,015
| – | – | 0.17% | 141 |
|
|
2022
Q3 | $236K | Hold |
2,015
| – | – | 0.18% | 147 |
|
|
2022
Q2 | $237K | Hold |
2,015
| – | – | 0.17% | 151 |
|
|
2022
Q1 | $263K | Hold |
2,015
| – | – | 0.17% | 157 |
|
|
2021
Q4 | $308K | Buy |
+2,015
| New | +$308K | 0.27% | 109 |
|